ClinicalTrials.Veeva

Menu

Characterization of Cancer Tissue Using 3D Biosynthetic Material

T

Technion, Israel Institute of Technology

Status

Unknown

Conditions

Cancer

Treatments

Procedure: Analyzing biopsy samples

Study type

Observational

Funder types

Other

Identifiers

NCT02678078
0671-15-RMB

Details and patient eligibility

About

Characterization of Cancer Tissue Using 3D Biosynthetic Materials. Using liver biopsy from stage 4 cancer patients, the investigators will evaluate and characterize the metastatic cells.

Full description

The investigators' biomaterial lab has developed an in vitro diagnostic system in which a cancer tumor is placed inside a 3D hydrogel. This material has similar properties to the human tissue and can visualize cell migration and proliferation. In this system, the investigators have already characterised human metastatic cells obtained from nude mice tumors. The diagnostic assay is able to evaluate the reduction in cell growth associated with anti-cancer drug therapy. The next step is to test the in vitro diagnostic system using human tissue samples from human patients, and to validate the system as a simple and effective a priori diagnostic tool for characterizing patient tumours.

Enrollment

100 estimated patients

Sex

All

Ages

18+ years old

Volunteers

Accepts Healthy Volunteers

Inclusion criteria

  • liver tumor

Exclusion criteria

  • refuse to volunteer

Trial contacts and locations

1

Loading...

Central trial contact

shlomit harpaz, Msc; tarek Saadi, Dr.

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2024 Veeva Systems